The ever-growing number of lawsuits filed against the manufacturer of the drug Reglan is at the center of debate over whether drug companies are immune from court action at the state level if their products are federally regulated.

There has been ongoing debate about whether generic drug makers are liable for side effects caused by their medications. The drug companies argue that the United States Food and Drug Administration’s mandate that generic drugs carry the same warning labels as their name brand counterparts relieves them of responsibility. This question is the focus of a lawsuit in Cincinnati, Ohio.

A court in Ohio ruled that generic drug maker was not responsible for the Tardive Dyskinesia a man developed after taking a generic form of Reglan. An appeals court is reconsidering the lawsuit and has requested the FDA provide its stance on this label issue, asking that an answer be delivered by July 29.

If you or someone you love has suffered from averse side-effects due to the prescription drug Reglan, call the Reglan tardive dyskinesia attorneys of Williams Kherkher at 800-781-3955 today.